The Liver as the Center of the Internal Defence System of the Body

A special issue of Livers (ISSN 2673-4389).

Deadline for manuscript submissions: closed (20 November 2024) | Viewed by 2174

Special Issue Editor

Special Issue Information

Dear Colleagues,

The liver, as the largest internal organ of the body, is located between the external alimentary system and the systemic circulation. On the one hand, it has to defend the organism from the dangers contained in food by eliminating them from the portal blood before they can reach the systemic circulation. On the other hand, the liver plays a central role in mounting a defensive response to those potentially noxious agents which reach the body from other routes by closely interacting with the bone marrow through the production of acute-phase cytokines and chemokines. The liver is the central organ of the acute-phase reaction, which is a central mechanism of defense that acts in several ways. Under such conditions, an increase in liver volume occurs, indicating that during an emergency (acute-phase) situation, one of the main functions of the liver—the synthesis of proteins involved in increasing the clearance capacity of foreign material from the circulation, such as those of the complement cascade and of those proteins of the coagulation system—is massively activated. While the first aims (opsonization) to increase the uptake of foreign material by the cells of the reticuloendothelial system in the liver, the proteins of the coagulation system are crucial for the formation of the “provisional clot” not only in cases of skin damage but also in the different cases of damage taking place in different organs, e.g., those caused by hypoxia. A quick activation of the clotting system, followed by the deposition of fibrin, fibronectin, and other proteins are crucial as a form of “first aid” to subsequently allow elimination of debris and repair of damaged tissue. The interaction of the endocrine system and the liver under such conditions is of great interest.

Prof. Dr. Giuliano Ramadori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Livers is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • clearance of: (a) bacteria and viruses, (b) particulate matter, (c) xenobiotics, and (d) aged erythrocytes and cellular debris
  • control of formation of the cellular components of the blood under normal and emergency situations
  • control of the production of the non-cellular parts of the blood: albumin, complement proteins, and coagulation proteins
  • control of blood pressure under normal and emergency situations
  • the endocrine system and the liver under normal and acute-phase conditions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 1387 KiB  
Review
Transplant Immunology in Liver Transplant, Rejection, and Tolerance
by Masaya Yokoyama, Daisuke Imai, Samuel Wolfe, Ligee George, Yuzuru Sambommatsu, Aamir A. Khan, Seung Duk Lee, Muhammad I. Saeed, Amit Sharma, Vinay Kumaran, Adrian H. Cotterell, Marlon F. Levy and David A. Bruno
Livers 2024, 4(3), 420-434; https://doi.org/10.3390/livers4030031 - 9 Sep 2024
Viewed by 1578
Abstract
Liver transplantation is the most effective treatment for end-stage liver disease. Despite improvements in surgical techniques, transplant rejection remains a significant concern. The liver is considered an immune-privileged organ due to its unique microenvironment and complex interactions among various cell types. Alloimmune responses [...] Read more.
Liver transplantation is the most effective treatment for end-stage liver disease. Despite improvements in surgical techniques, transplant rejection remains a significant concern. The liver is considered an immune-privileged organ due to its unique microenvironment and complex interactions among various cell types. Alloimmune responses mediated by T cells and antigen-presenting cells (APCs) play crucial roles in transplant rejection. The liver’s dual blood supply and unique composition of its sinusoidal endothelial cells (LSECs), Kupffer cells (KCs), hepatocytes, and hepatic stellate cells (HSCs) contribute to its immune privilege. Alloantigen recognition by T cells occurs through direct, indirect, and semidirect pathways, leading to acute cellular rejection (ACR) and chronic rejection. ACR is a T cell-mediated process that typically occurs within the first few weeks to months after transplantation. Chronic rejection, on the other hand, is a gradual process characterized by progressive fibrosis and graft dysfunction, often leading to graft loss. Acute antibody-mediated rejection (AMR) is less common following surgery compared to other solid organ transplants due to the liver’s unique anatomy and immune privilege. However, when it does occur, AMR can be aggressive and lead to rapid graft dysfunction. Despite improvements in immunosuppression, rejection remains a challenge, particularly chronic rejection. Understanding the mechanisms of rejection and immune tolerance, including the roles of regulatory T cells (Tregs) and hepatic dendritic cells (DCs), is crucial for improving transplant outcomes. Strategies to induce immune tolerance, such as modulating DC function or promoting Treg activity, hold promise for reducing rejection and improving long-term graft survival. This review focuses on the liver’s unique predisposition to rejection and tolerance, highlighting the roles of individual cell types in these processes. Continued research into the mechanisms of alloimmune responses and immune tolerance in liver transplantation is essential for developing more effective therapies and improving long-term outcomes for patients with end-stage liver disease. Full article
(This article belongs to the Special Issue The Liver as the Center of the Internal Defence System of the Body)
Show Figures

Figure 1

Back to TopTop